Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.

Hall AL, Karvounides D, Gelfand AA, Mankin H, Kessel S, Corroo J, Malavolta CP, Pezzuto T, Chadehumbe M, Szperka CL.

Headache. 2019 Jun 5. doi: 10.1111/head.13570. [Epub ahead of print]

PMID:
31165479
2.

Preliminary Evidence that Melatonin Is not a Biomarker in Children and Adolescents With Episodic Migraine.

Berger A, Litwin J, Allen IE, Qubty W, Irwin S, Waung M, Gelfand AA.

Headache. 2019 May 3. doi: 10.1111/head.13547. [Epub ahead of print]

PMID:
31054199
3.

High School Start Time and Migraine Frequency in High School Students.

Gelfand AA, Pavitt S, Greene K, Szperka CL, Irwin S, Grimes B, Allen IE.

Headache. 2019 Apr 24. doi: 10.1111/head.13535. [Epub ahead of print]

PMID:
31016722
4.

Assessing evidence-based medicine and opioid/barbiturate as first-line acute treatment of pediatric migraine and primary headache: A retrospective observational study of health systems data.

Seng EK, Gelfand AA, Nicholson RA.

Cephalalgia. 2019 Feb 20:333102419833080. doi: 10.1177/0333102419833080. [Epub ahead of print]

PMID:
30786733
5.

Potential Benefits of Migraine-What Is It Good For?

Gelfand AA, Loder E.

JAMA Neurol. 2018 Dec 17. doi: 10.1001/jamaneurol.2018.3442. [Epub ahead of print] No abstract available.

PMID:
30556821
6.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Szperka CL, VanderPluym J, Orr SL, Oakley CB, Qubty W, Patniyot I, Lagman-Bartolome AM, Morris C, Gautreaux J, Victorio MC, Hagler S, Narula S, Candee MS, Cleves-Bayon C, Rao R, Fryer RH, Bicknese AR, Yonker M, Hershey AD, Powers SW, Goadsby PJ, Gelfand AA.

Headache. 2018 Nov;58(10):1658-1669. doi: 10.1111/head.13414. Epub 2018 Oct 15. No abstract available.

PMID:
30324723
7.

Pediatric and Adolescent Headache.

Gelfand AA.

Continuum (Minneap Minn). 2018 Aug;24(4, Headache):1108-1136. doi: 10.1212/CON.0000000000000638.

PMID:
30074552
8.

Occipital Headaches and Neuroimaging in Children.

Irwin SL, Gelfand AA.

Curr Pain Headache Rep. 2018 Jul 10;22(9):59. doi: 10.1007/s11916-018-0712-6. Review.

PMID:
29987497
9.

Cluster Headache and Calcitonin Gene-Related Peptide-More on Quantum Therapeutics in Headache Medicine.

Gelfand AA, Goadsby PJ.

JAMA Neurol. 2018 Oct 1;75(10):1179-1180. doi: 10.1001/jamaneurol.2018.1428. No abstract available.

PMID:
29987331
10.

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.

Dodick DW, Tepper SJ, Friedman DI, Gelfand AA, Kellerman DJ, Schmidt PC.

Headache. 2018 Jul;58(7):986-992. doi: 10.1111/head.13327. Epub 2018 May 21.

11.

Episodic syndromes of childhood associated with migraine.

Gelfand AA.

Curr Opin Neurol. 2018 Jun;31(3):281-285. doi: 10.1097/WCO.0000000000000558. Review.

PMID:
29601304
12.

Migraine is common in patients with sarcoidosis.

Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL.

Cephalalgia. 2018 Dec;38(14):2079-2082. doi: 10.1177/0333102418768037. Epub 2018 Mar 26.

PMID:
29580067
13.

Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.

Irwin SL, Qubty W, Allen IE, Patniyot I, Goadsby PJ, Gelfand AA.

Headache. 2018 May;58(5):724-731. doi: 10.1111/head.13284. Epub 2018 Mar 12.

PMID:
29528485
14.

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).

Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW.

Cephalalgia. 2018 May;38(6):1038-1048. doi: 10.1177/0333102418762525. Epub 2018 Mar 4.

15.

Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.

Buse DC, Powers SW, Gelfand AA, VanderPluym JH, Fanning KM, Reed ML, Adams AM, Lipton RB.

Headache. 2018 Apr;58(4):512-524. doi: 10.1111/head.13254. Epub 2018 Jan 22.

PMID:
29355924
16.

Experts' opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta.

Özge A, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Faedda N, Lipton RB, Rapoport A, Guidetti V.

J Headache Pain. 2017 Nov 29;18(1):113. doi: 10.1186/s10194-017-0819-x.

17.

Experts' opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents.

Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Lipton RB, Rapoport A, Guidetti V.

J Headache Pain. 2017 Nov 23;18(1):109. doi: 10.1186/s10194-017-0818-y. Review.

18.

Occipital headaches and neuroimaging in children.

Bear JJ, Gelfand AA, Goadsby PJ, Bass N.

Neurology. 2017 Aug 1;89(5):469-474. doi: 10.1212/WNL.0000000000004186. Epub 2017 Jun 30.

19.

Pediatric Migraine Prevention-First, Do No Harm.

Gelfand AA, Qubty W, Goadsby PJ.

JAMA Neurol. 2017 Aug 1;74(8):893-894. doi: 10.1001/jamaneurol.2017.1011. Review. No abstract available.

PMID:
28628697
20.

Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.

Tso AR, Patniyot IR, Gelfand AA, Goadsby PJ.

Neurology. 2017 Jul 18;89(3):279-283. doi: 10.1212/WNL.0000000000004108. Epub 2017 Jun 14.

21.

Melatonin in the Treatment of Primary Headache Disorders.

Gelfand AA.

Headache. 2017 Jun;57(6):848-849. doi: 10.1111/head.13138. No abstract available.

PMID:
28594124
22.

Home-Based Trials in Adolescent Migraine: A Randomized Clinical Trial.

Gelfand AA, Qubty W, Patniyot I, Grimes B, Pletcher MJ, Goadsby PJ, Cummings SR.

JAMA Neurol. 2017 Jun 1;74(6):744-745. doi: 10.1001/jamaneurol.2017.0285. No abstract available.

23.

Acupuncture for Migraine Prevention: Still Reaching for Convincing Evidence.

Gelfand AA.

JAMA Intern Med. 2017 Apr 1;177(4):516-517. doi: 10.1001/jamainternmed.2016.9404. No abstract available.

PMID:
28241222
24.

Neck-Tongue syndrome: A systematic review.

Gelfand AA, Johnson H, Lenaerts ME, Litwin JR, De Mesa C, Bogduk N, Goadsby PJ.

Cephalalgia. 2018 Feb;38(2):374-382. doi: 10.1177/0333102416681570. Epub 2017 Jan 18.

PMID:
28100071
25.

Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents.

Qubty W, Gelfand AA.

Curr Pain Headache Rep. 2016 Dec;20(12):69. Review.

PMID:
27896587
26.
27.

The Role of Melatonin in the Treatment of Primary Headache Disorders.

Gelfand AA, Goadsby PJ.

Headache. 2016 Sep;56(8):1257-66. doi: 10.1111/head.12862. Epub 2016 Jun 17. Review.

28.

The Link Between Infantile Colic and Migraine.

Qubty W, Gelfand AA.

Curr Pain Headache Rep. 2016 May;20(5):31. doi: 10.1007/s11916-016-0558-8. Review.

PMID:
27038970
29.

Infant Colic.

Gelfand AA.

Semin Pediatr Neurol. 2016 Feb;23(1):79-82. doi: 10.1016/j.spen.2015.08.003. Epub 2015 Aug 17. Review.

30.

Review of Prevention for Pediatric and Adolescent Migraine.

Qubty W, Gelfand AA.

Pediatr Neurol Briefs. 2016 Jan;30(1):5. doi: 10.15844/pedneurbriefs-30-1-4.

31.

Predictors of Triptan Response in Pediatric Migraine.

Johnson HF, Goadsby PJ, Gelfand AA.

Pediatr Neurol. 2016 May;58:37-40. doi: 10.1016/j.pediatrneurol.2016.01.022. Epub 2016 Mar 8.

32.

Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.

Eller M, Gelfand AA, Riggins NY, Shiboski S, Schankin C, Goadsby PJ.

Neurology. 2016 Mar 1;86(9):856-9. doi: 10.1212/WNL.0000000000002406. Epub 2016 Feb 3.

33.

Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic Review.

Patniyot IR, Gelfand AA.

Headache. 2016 Jan;56(1):49-70. doi: 10.1111/head.12746. Review.

PMID:
26790849
34.

Cyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations.

Gelfand AA, Gallagher RC.

Headache. 2016 Jan;56(1):215-21. doi: 10.1111/head.12749. Epub 2015 Dec 18.

35.

Episodic Syndromes That May Be Associated With Migraine: A.K.A. "the Childhood Periodic Syndromes".

Gelfand AA.

Headache. 2015 Nov-Dec;55(10):1358-64. doi: 10.1111/head.12624. Epub 2015 Aug 3. Review.

36.

Psychiatric comorbidity and paediatric migraine: examining the evidence.

Gelfand AA.

Curr Opin Neurol. 2015 Jun;28(3):261-4. doi: 10.1097/WCO.0000000000000192. Review.

PMID:
25923126
37.

Is migraine a risk factor for pediatric stroke?

Gelfand AA, Fullerton HJ, Jacobson A, Sidney S, Goadsby PJ, Kurth T, Pressman A.

Cephalalgia. 2015 Dec;35(14):1252-60. doi: 10.1177/0333102415576222. Epub 2015 Mar 9.

38.

Infant colic--a baby's migraine?

Gelfand AA.

Cephalalgia. 2015 Dec;35(14):1243-5. doi: 10.1177/0333102415576224. Epub 2015 Mar 2. No abstract available.

PMID:
25733672
39.

Migraine in young children.

Gelfand AA.

Dev Med Child Neurol. 2015 Jun;57(6):503. doi: 10.1111/dmcn.12697. Epub 2015 Jan 23. No abstract available.

40.

Medication overuse in children and adolescents.

Gelfand AA, Goadsby PJ.

Curr Pain Headache Rep. 2014 Jul;18(7):428. doi: 10.1007/s11916-014-0428-1. Review.

41.

The relationship between migraine and infant colic: a systematic review and meta-analysis.

Gelfand AA, Goadsby PJ, Allen IE.

Cephalalgia. 2015 Jan;35(1):63-72. doi: 10.1177/0333102414534326. Epub 2014 May 22. Review.

PMID:
24853164
42.

Teaching neuroimages: infant with glutaric aciduria type 1 presenting with infantile spasms and hypsarrhythmia.

Young-Lin N, Shalev S, Glenn OA, Gardner M, Lee C, Wynshaw-Boris A, Gelfand AA.

Neurology. 2013 Dec 10;81(24):e182-3. doi: 10.1212/01.wnl.0000437291.75075.53.

43.

Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.

Gelfand AA, Reider AC, Goadsby PJ.

Pediatr Neurol. 2014 Feb;50(2):135-9. doi: 10.1016/j.pediatrneurol.2013.09.008. Epub 2013 Nov 20.

44.

Childhood migraine is associated with a history of infantile colic.

Gelfand AA.

J Pediatr. 2013 Sep;163(3):922-3. doi: 10.1016/j.jpeds.2013.06.048. No abstract available.

PMID:
23973242
45.

Cranial autonomic symptoms in pediatric migraine are the rule, not the exception.

Gelfand AA, Reider AC, Goadsby PJ.

Neurology. 2013 Jul 30;81(5):431-6. doi: 10.1212/WNL.0b013e31829d872a. Epub 2013 Jun 28.

46.

Migraine and childhood periodic syndromes in children and adolescents.

Gelfand AA.

Curr Opin Neurol. 2013 Jun;26(3):262-8. doi: 10.1097/WCO.0b013e32836085c7. Review.

PMID:
23549418
47.

Migraine and multiple sclerosis: Epidemiology and approach to treatment.

Gelfand AA, Gelfand JM, Goadsby PJ.

Mult Scler Relat Disord. 2013 Apr;2(2):73-9. doi: 10.1016/j.msard.2012.10.003. Epub 2013 Jan 16. Review.

PMID:
25877626
48.

Genetic risk factors for perinatal arterial ischemic stroke.

Gelfand AA, Croen LA, Torres AR, Wu YW.

Pediatr Neurol. 2013 Jan;48(1):36-41. doi: 10.1016/j.pediatrneurol.2012.09.016.

49.

Before the headache: infant colic as an early life expression of migraine.

Gelfand AA, Thomas KC, Goadsby PJ.

Neurology. 2012 Sep 25;79(13):1392-6. Epub 2012 Sep 12.

50.

Treatment of pediatric migraine in the emergency room.

Gelfand AA, Goadsby PJ.

Pediatr Neurol. 2012 Oct;47(4):233-41. doi: 10.1016/j.pediatrneurol.2012.06.001. Review.

Supplemental Content

Loading ...
Support Center